Financhill
Back

CASI Pharmaceuticals Stock Predictions

CASI Pharmaceuticals Stock Forecast

  • Is CASI Pharmaceuticals Stock Undervalued?
    The current CASI Pharmaceuticals [CASI] share price is $2.82. The Score for CASI is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • CASI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will CASI Pharmaceuticals Stock Go Up Next Year?

Data Unavailable

CASI Pharmaceuticals Stock Rating

Data Unavailable

CASI Pharmaceuticals Stock Price History

Is CASI stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CASI is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
China
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
casipharmaceuticals.com

52-Week Data

52-Week High:
8.19
52-Week Low:
2.05

Prediction Charts

Market Cap:
43.6M
Price in USD:
2.82
Volume:
163.2K
Beta:
1.46

Technical Analysis

SMA50:
4.70
SMA100:
5.53
SMA200:
4.71
52-Wk Change:
-55.87%

Stock Predictions

  • Is CASI Pharmaceuticals stock public?
    Yes, CASI Pharmaceuticals is a publicly traded company.
  • What is the CASI Pharmaceuticals stock quote today?
    The CASI Pharmaceuticals stock price is 2.82 USD today.
  • How to buy CASI Pharmaceuticals stock online?
    You can buy CASI Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-5 3.38 2.81 3.46 2.70
Dec-6 2.94 3.63 3.67 2.88
Dec-9 3.55 3.89 3.97 3.46
Dec-10 3.74 3.43 3.90 3.25
Dec-11 3.33 3.12 3.54 3.11
Dec-12 3.16 3.07 3.34 2.88
Dec-13 3.07 3.11 3.47 3.07
Dec-16 3.13 3.15 3.33 3.00
Dec-17 3.10 3.02 3.32 2.86
Dec-18 3.15 2.86 3.15 2.86
Dec-19 2.89 2.69 2.97 2.50
Dec-20 2.72 2.65 2.82 2.65
Dec-23 2.54 2.68 2.69 2.53
Dec-24 2.58 2.82 3.28 2.50

CASI Pharmaceuticals Earnings

Data Unavailable

CASI Pharmaceuticals Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.93 per share, and an increase next year of $0.34 per share.

* CASI Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.